Toublanc M - Search Results

1

Value of the preoperative detection of prostate-specific-antigen-positive circulating cells by nested RT-PCR in patients submitted to radical prostatectomy.

de Cremoux P, Ravery V, Podgorniak MP, Chevillard S, Toublanc M, Thiounn N, Tatoud R, Delmas V, Calvo T, Boccon-Gibod L. de Cremoux P, et al. Among authors: toublanc m. Eur Urol. 1997;32(1):69-74. Eur Urol. 1997. PMID: 9266235

2

Prostate cancer characteristics in a multiracial community.

Ravery V, Dominique S, Hupertan V, Ben Rhouma S, Toublanc M, Boccon-Gibod L, Boccon-Gibod L. Ravery V, et al. Among authors: toublanc m. Eur Urol. 2008 Mar;53(3):533-8. doi: 10.1016/j.eururo.2007.04.048. Epub 2007 Apr 23. Eur Urol. 2008. PMID: 17467885

3

The 20-core prostate biopsy protocol--a new gold standard?

Ravery V, Dominique S, Panhard X, Toublanc M, Boccon-Gibod L, Boccon-Gibod L. Ravery V, et al. Among authors: toublanc m. J Urol. 2008 Feb;179(2):504-7. doi: 10.1016/j.juro.2007.09.033. J Urol. 2008. PMID: 18076947

4

Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy.

Ravery V, Boccon-Gibod LA, Dauge-Geffroy MC, Billebaud T, Delmas V, Meulemans A, Toublanc M, Boccon-Gibod L. Ravery V, et al. Among authors: toublanc m. Urology. 1994 Sep;44(3):371-6. doi: 10.1016/s0090-4295(94)80095-2. Urology. 1994. PMID: 7521093

5

Predictive value of pathological features for progression after radical prostatectomy.

Ravery V, Boccon-Gibod LA, Meulemans A, Dauge-Geffroy MC, Toublanc M, Boccon-Gibod L. Ravery V, et al. Among authors: toublanc m. Eur Urol. 1994;26(3):197-201. doi: 10.1159/000475379. Eur Urol. 1994. PMID: 7528660

6

Perineal versus retropubic radical prostatectomy for T1, T2 prostate cancer.

Haab F, Boccon-Gibod L, Delmas V, Boccon-Gibod L, Toublanc M. Haab F, et al. Among authors: toublanc m. Br J Urol. 1994 Nov;74(5):626-9. doi: 10.1111/j.1464-410x.1994.tb09195.x. Br J Urol. 1994. PMID: 7530127

7

Prostate specimen reevaluation in patients with organ confined prostate cancer and postoperative biological recurrence.

Ravery V, De la Taille A, Toublanc M, Boccon-Gibod L, Hermieu JF, Delmas V, Boccon-Gibod L. Ravery V, et al. Among authors: toublanc m. J Urol. 1996 Jun;155(6):1981-2. J Urol. 1996. PMID: 8618302

8

Early detection of prostate cancer in men with prostatism and intermediate prostate-specific antigen levels.

Schmid HP, Ravery V, Billebaud T, Toublanc M, Boccon-Gibod LA, Hermieu JF, Delmas V, Boccon-Gibod L. Schmid HP, et al. Among authors: toublanc m. Urology. 1996 May;47(5):699-703. doi: 10.1016/s0090-4295(96)00018-0. Urology. 1996. PMID: 8650868 Clinical Trial.

9

[Detection of prostatic cancer in symptomatic patients with serum levels of prostate-specific antigen between 4 and 10 ng/ml].

Ravery V, Schmid HP, Billebaud T, Toublanc M, Boccon-Gibod L, Hermieu JF, Delmas V, Boccon-Gibod L. Ravery V, et al. Among authors: toublanc m. Presse Med. 1996 Feb 24;25(7):272-6. Presse Med. 1996. PMID: 8685164 French.

10

A single positive prostate biopsy in six does not predict a low-volume prostate tumour.

Ravery V, Szabo J, Toublanc M, Boccon-Gibod LA, Billebaud T, Hermieu JF, Delmas V, Boccon-Gibod L. Ravery V, et al. Among authors: toublanc m. Br J Urol. 1996 May;77(5):724-8. doi: 10.1046/j.1464-410x.1996.98619.x. Br J Urol. 1996. PMID: 8689119

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters